Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
Saved in:
| Title: | Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial. |
|---|---|
| Authors: | Boesing M; University Clinic of Medicine, Cantonal Hospital Baselland, Rheinstrasse 26, CH-4410, Liestal, Switzerland. maria.boesing@ksbl.ch.; Faculty of Medicine, University of Basel, Klingelbergstrasse 61, CH-4056, Basel, Switzerland. maria.boesing@ksbl.ch., Abig K; University Clinic of Medicine, Cantonal Hospital Baselland, Rheinstrasse 26, CH-4410, Liestal, Switzerland., Brändle M; Cantonal Hospital St. Gallen, Rorschacherstrasse 95, CH-9007, St. Gallen, Switzerland., Brutsche M; Cantonal Hospital St. Gallen, Rorschacherstrasse 95, CH-9007, St. Gallen, Switzerland., Burri E; University Clinic of Medicine, Cantonal Hospital Baselland, Rheinstrasse 26, CH-4410, Liestal, Switzerland., Frye BC; Department of Pneumology, Medical Center University of Freiburg, Kilianstrasse 5, 79106, Freiburg, Germany., Giezendanner S; University Clinic of Medicine, Cantonal Hospital Baselland, Rheinstrasse 26, CH-4410, Liestal, Switzerland., Grutters JC; St. Antonius Hospital Nieuwegein, Koekoekslaan 1, NL-3435, Nieuwegein, Netherlands.; Division of Heart & Lungs, University Medical Center Utrecht, Heidelberglaan 100, NL-3584, Utrecht, Netherlands., Haas P; AdVita Lifescience GmbH, Alte Bundesstrasse 20, 79194, Gundelfingen, Germany., Heisler J; University Clinic of Medicine, Cantonal Hospital Baselland, Rheinstrasse 26, CH-4410, Liestal, Switzerland.; Faculty of Medicine, University of Basel, Klingelbergstrasse 61, CH-4056, Basel, Switzerland., Jaun F; University Clinic of Medicine, Cantonal Hospital Baselland, Rheinstrasse 26, CH-4410, Liestal, Switzerland., Leuppi-Taegtmeyer AB; University Clinic of Medicine, Cantonal Hospital Baselland, Rheinstrasse 26, CH-4410, Liestal, Switzerland.; Department of Clinical Pharmacology and Toxicology, University Hospital Basel, University of Basel, Basel, Switzerland., Lüthi-Corridori G; University Clinic of Medicine, Cantonal Hospital Baselland, Rheinstrasse 26, CH-4410, Liestal, Switzerland.; Faculty of Medicine, University of Basel, Klingelbergstrasse 61, CH-4056, Basel, Switzerland., Müller-Quernheim J; Department of Pneumology, Medical Center University of Freiburg, Kilianstrasse 5, 79106, Freiburg, Germany., Nüesch R; Hospital Schwyz, Waldeggstrasse 10, CH-6430, Schwyz, Switzerland., Pohl W; Karl Landsteiner Institute for Clinical and Experimental Pneumology, Clinic Hietzing, Wolkersbergenstrasse 1, A-1130, Vienna, Austria., Rassouli F; Cantonal Hospital St. Gallen, Rorschacherstrasse 95, CH-9007, St. Gallen, Switzerland., Leuppi JD; University Clinic of Medicine, Cantonal Hospital Baselland, Rheinstrasse 26, CH-4410, Liestal, Switzerland.; Faculty of Medicine, University of Basel, Klingelbergstrasse 61, CH-4056, Basel, Switzerland. |
| Source: | Trials [Trials] 2022 Sep 20; Vol. 23 (1), pp. 790. Date of Electronic Publication: 2022 Sep 20. |
| Publication Type: | Clinical Trial Protocol; Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1745-6215 |
|---|---|
| DOI: | 10.1186/s13063-022-06723-w |
